Creyon Bio
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- Undisclosed
Investors
- 5
About Creyon Bio
Based in California, US, and founded in 2019 by its CEO Chris Hart and CSO Swagatam, Creyon Bio, Inc. operates as a drug development platform. In March 2022, Creyon Bio, Inc. Creyon Bio operates as a drug company that provides (ribonucleic acid) RNA-based medicines and oligonucleotide-based medicines (OBMs) which are used in various respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). The company’s offerings include purpose-built datasets that feed into sophisticated machine learning models, quickly discovering design rules and engineering principles for safe and effective OBMs (Oligonucleotide-based medicines).
Who invested in Creyon Bio
5 investors across 1 round
See all investors in Creyon Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 8, 2022
Amount
Undisclosed
Investors
Questions about Creyon Bio
Who invested in Creyon Bio?
Creyon Bio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Creyon Bio raised?
Creyon Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Creyon Bio last raise money?
Creyon Bio's most recent round on record is a Series A, in Mar 2022.
What does Creyon Bio do?
Based in California, US, and founded in 2019 by its CEO Chris Hart and CSO Swagatam, Creyon Bio, Inc.
Where is Creyon Bio headquartered?
Creyon Bio is headquartered in Sam Diego, US.
Which VCs invest in companies like Creyon Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Creyon Bio's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Creyon Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.